Wyss Institute at Harvard University

About Wyss Institute at Harvard University

The Wyss Institute at Harvard University leverages Nature's genius to tackle urgent global challenges in human and planetary health. It combines academic science with industry speed to turn groundbreaking discoveries into market-ready solutions, creating a cascade of innovation termed 'The Wyss Effect'. The institute focuses on areas such as cancer, women's health, brain health, aging, infectious disease, and environmental sustainability.

Products & Services

Gameto - Human Ovarian Organoids:Uses fully human ovarian organoid technology to improve women's health by making IVF safer, cheaper, and more accessible.

eGenesis - Engineered Pig Organs:Aims to end the global transplant shortage by using CRISPR to edit pig genomes, making their organs safe for human transplantation.

Emulate, Inc. - Human Organs-on-Chips:Microfluidic devices lined with human cells for drug development, disease modeling, and personalized medicine, enabling faster and cheaper drug development.

NodeTX - Immunotherapy:Develops temporary lymph nodes to treat cancer.

RNA Therapeutic for COVID-19 & Flu:A broad-spectrum RNA therapy for treating COVID-19 and influenza.

Specialties

Biologically-Inspired Engineering Cancer Treatment Women's Health Brain Health Aging Infectious Disease Environmental Sustainability Organ Transplantation Drug Development Personalized Medicine

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Contract T: - FT: Contract	A: 25000000 MR: - FA: up to $25M FAN: 25000000	D: 2026-01-13 FD: 2026-01-13	1 investors

Contract Latest

2026-01-13

$25.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

H

Hansjörg Wyss

Recent News